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Abstract
Background: To the best of our knowledge, no empirically based consensus has been reached as to if, and to
what extent, persons with hearing loss (HL) have reduced generic Quality of life (QoL). There seems to be limited
knowledge regarding to what extent a hearing aid (HA) would improve QoL. The main aim of the present study
was to review studies about the relationship between HL and QoL. A supporting aim was to study the association
between distress and HL.
Methods: Literature databases (Cinahl, Pub Med and Web of Science) were searched to identify relevant journal
articles published in the period from January 2000 to March 17, 2016. We performed a primary search pertaining to
the relationship between HL, HA and QoL (search number one) followed by a supporting search pertaining to the
relationship between distress/mood/anxiety and HL (search number two). After checking for duplications and
screening the titles of the papers, we read the abstracts of the remaining papers. The most relevant papers were
read thoroughly, leaving us with the journal articles that met the inclusion criteria.
Results: Twenty journal articles were included in the present review: 13 were found in the primary search (HL and
QoL), and seven in the supporting search (HL and distress). The literature yields equivocal findings regarding the
association between generic QoL and HL. A strong association between distress and HL was shown, where
distressed persons tend to have a lowered generic QoL. It is suggested that QoL is lowered among HL
patients. Some studies suggest an increased generic QoL following the use of HA, especially during the first
few months after initiation of treatment. Other studies suggest that HA use is one of several possible
factors that contribute to improve generic QoL.
Conclusions: The majority of the studies suggest that HL is associated with reduced generic QoL. Using
hearing aids seem to improve general QoL at follow-up within the first year. HL is a risk factor for distress.
Further research is needed to explore the relationship between HL and generic QoL, in addition to the
importance of influencing variables on this relationship.
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Background
In 2012, the World Health Organization (WHO) esti-
mated that 360 million people, i.e. 5.3% of the world’s
population, were living with disabling hearing loss (HL),
while around 15% of the world’s adult population had
some degree of HL [1]. Furthermore, sensory diseases
have been estimated to be the world’s second most
common group of chronic disability when measured by
years lived with disability [2]. HL increases with age,
mostly because of age-related HL, generally referred to
as presbyacusis. This term represents the sum of the
environmental, sensory, metabolic and neural causes
that to various extents are suggested to contribute to
age-related physiological hearing loss [3, 4]. Presbyacusis
cause reduced speech understanding in noisy
environments, declined processing of acoustic informa-
tion and impaired localization of sound sources [4].
Hearing loss is present in nearly two thirds of adults
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aged 70 years and older in the U.S. population [5]. Even
though most people with HL suffer from presbyacusis,
other factors such as other ear diseases [6], occupational
noise exposure [7] and specific genetic diseases [8] may
cause HL. Thus, HL may affect people at all ages and
stages in life [9].
HL is often characterized by at which sound pres-
sure level pure tones can be detected employing
standard audiometric tests [3]. Presbyacusis typically
causes a symmetric bilateral high frequency hearing
loss. As human speech is related to relatively high
frequencies, even a limited hearing loss at high fre-
quencies may cause impaired speech intelligibility
[10]. HL is often not curable, but hearing aids (HA)
and other individual sound amplification devices
(ISADs) may improve hearing function [11].
Patient reported outcome measures (PROMs), such
as Quality of life (QoL) questionnaires, should ideally
be systematically implemented in health care practices
[12] as there seems to be a need for a more “holistic”
approach within a modern view of health care. This
calls for the inclusion of both disease-specific and
generic QoL outcome measures [13]. QoL measures
constitute important outcome- and state measures
[14, 15], as well as an area of focus for research in its
own right [14, 15]. However, there is no universally
accepted definition for the concept of QoL [16, 17].
Even so, we all have a notion about what QoL is, and
most people seem to have an intuitive understanding
of their own QoL by referring to their own percep-
tion [16]. Thus, the concept QoL will hold different
contents among different people [16].
WHO defines QoL as “An individual’s perception of
their position on life in the context of the culture and
value systems in which they live and in relation to their
goals, expectations, standards and concerns.” This is a
broad-ranging concept related to a person’s physical
health, psychological state, level of independence, social
relationships, personal beliefs and their relationship to
salient features of their own environment. The WHO
QoL definition is closely related to the WHO’s definition
of health from 1948, which describes health as “physical,
mental and social well-being, and not merely the ab-
sence of disease or infirmity” [16]. This is also a wide
definition, in which in addition to a physical dimension,
the WHO also includes well- being, environmental and
psychological factors as part of health. Hence, both gen-
eric and disease-specific QoL become relevant as to dis-
ease and health [18].
Many different questionnaires have been developed
with the intent of directly measuring the functional
consequences of a disease; these may be termed “dis-
ease-specific” QoL questionnaires. Thus, QoL instru-
ments intended to study the specific consequences of
HL may be considered examples of such instruments
[19]. The effect of HL on hearing function can usu-
ally be measured by hearing-specific questionnaires
[20], but to what extent HL affects generic QoL is
not well agreed upon and constitutes the main aim of
this study.
The most commonly used generic QoL questionnaire
is the SF- 36, with more than 13,000 “hits” on Pubmed
as of 2016. The SF-36 measures functional status and
wellbeing [21]. This questionnaire was first used in a
provisional edition in 1988 and in a standard form in
1990 [22]. Shortened questionnaires have been devel-
oped from this original, i.e. the 12-item questionnaire
SF-12 [23]. Another commonly used generic question-
naire is the Euro-QoL instrument (EQ-5D). This is a
standardized questionnaire intended to measure generic
QoL [24], and it may be utilized within a wide range of
health conditions. The EQ-5D describes five dimen-
sions: mobility, self-care, usual activities, pain/discom-
fort and anxiety/depression. An index value is
calculated for each individual, ranging from 1, which
indicates no problems in all five dimensions, to 15,
which indicate severe problems in all five dimensions.
Other generic questionnaires that may be used are the
Health Utility Index (HUI) and the Sickness Impact
Profile (SIP) [25, 26]. General parts of disease-related
questionnaires, such as the European Organization for
the Research and Treatment of Cancer (EORTC) Qual-
ity of Life Questionnaire (QLQ) may also be considered
generic QoL instruments [27]. Disease specific ques-
tionnaires may also include some questions about gen-
eric QoL. However, generic QoL instruments measure
many aspects of QoL, and are often intended for use
over a wide range of diseases. Such questionnaires are
often also applicable to healthy people. Thus, generic
QoL questionnaires allow comparing QoL between pa-
tient groups, as well as to data from general popula-
tions [16, 28]. The specific main aim of the present
study is to review the existing literature on generic QoL
obtained by generic instruments among hearing-
impaired patients.
In order to assess generic QoL within a disease
context, important modulating factors known to con-
tribute to QoL may be assessed alongside the QoL
measure. This may include psychosocial factors [29],
personality [30, 31] and factors related to activities of
daily living [32]. To study potential modulating condi-
tions in the relationship between HL and QoL has
therefore been a supporting aim when reviewing the
literature in the present study.
QoL as a construct seems to be closely associated
with distress, anxiety, and mood, when measured pri-
marily in generic, but also to some extent in disease-
specific QoL questionnaires [20, 33–35]. Hence, it
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should be of interest to study the impact of HL on dis-
tress, mood and depression. Anxiety and depression
can be defined using standardized classification man-
uals such as the ICD-10 [36] or DSM-5 [37], while dis-
tress seems to have no such clear and universal
definition. However, one may understand psychological
distress as a unique discomforting, emotional state ex-
perienced by an individual that results in harm to the
person, either temporarily or permanently [38]. In psy-
chological research, distress is often quantified as the
sum of anxiety and lowered mood [39]. Distress may
also be utilized as an indicator of mental disease [39].
Thus, as QoL, distress, mood and anxiety are closely
related concepts [40], we have conducted a search for
the major publications on associations between HL
and distress, anxiety and mood in order to present a
more complete picture of the associations between HL
and generic QoL.
Aim of this paper
So far, no empirically based consensus about if, and in
case to what extent, HL patients have reduced generic
QoL has been reached. The main aim of this study was
to review studies on the relationship between HL and
generic QoL published in the period 2000 to present
day. As a supporting aim we have also determined noted
psychological explaining factors reported in the above-
identified publications. As an additional investigational
tool, we have reviewed papers from the same period that
study HL and distress, anxiety and mood. This was done
because level of distress, anxiety and mood seems closely
associated to generic QoL.
Method
Design
Data were collected using a systematized literature re-
view design. We performed two separate searches for
relevant papers. Search number one targeted HL, HA
and QoL, whereas search number two targeted HL and
distress, anxiety and depression. The Prisma 2009 check-
list [41] was applied during the process of writing this
paper, and is available as Additional file 1.
Searches
We suggest that literature produced over the past 15–
16 years would contain most of the significant findings
and results from prior studies [42]. Based on this, we set
the time frame from the year 2000 up to the search date
to obtain relevant literature. Moreover, we only included
studies based on empirical data with an available ab-
stract. To help narrow down the two searches in order
to meet the specific aims of this study, we excluded
studies concerning the hearing impaired peers or family
or other caregivers. Other exclusion criteria were studies
on deafness, persons with cochlea implants, dual or
multi-sensorial loss, tinnitus, stigma and HL, assistive
listening devices, bone-anchored hearing aids, HL and
psychiatric disease, HA usage, sudden sensorineural HL,
conductive HL and surgical interventions on HL. We
also excluded qualitative studies as well as studies on
psychiatric diseases and depression or anxiety prior to
the HL.
Search number one - HL, HA and QoL
In the primary search, we included peer reviewed ori-
ginal papers in English published in the period from
January 2000 to March 17, 2016 (search date). Studies
on QoL or health-related QoL in adult persons with sen-
sorineural hearing loss or presbyacusis were included.
To identify relevant studies, we performed a search in
the databases Cinahl, Pub Med and Web of Science. We
used combinations (AND) of the following keywords:
1. Hearing disorders OR deafness OR hearing loss/
partial + OR hearing loss/sensorineural + OR
Tinnitus AND hearing aid OR Hearing aid fitting
AND hearing loss OR hard of hearing OR loss of
hearing OR hearing impair* OR hearing disorder*
OR deaf* OR hearing aid* OR hearing assistive
technology.
2. Quality of life + OR Quality of Life OR health-related
Quality of life OR HRQoL OR qol.
A total of 3280 papers were found in the introductory
search. After checking for duplications and screening
the titles of the papers, 151 papers remained; Cinahl (n
= 17), Pub Med (n = 43) and Web of Science (n = 91).
After reading the abstracts, the remaining 35 papers
were retained and thoroughly read. This left us with 13
journal articles that met the inclusion criteria (Fig. 1).
Search number two - HL and distress, anxiety and
depression
From the supporting search we included peer-reviewed
original papers in English published in the period from
January 2000 to October 26, 2016 (search date). This
search was aimed at studies on distress, depression and/
or anxiety caused by the hearing impairment, in adults
with sensorineural HL.
To identify relevant studies, we performed a search on
October 26, 2016, using the databases Cinahl, Pub Med
and the Web of Science.
A total of 1157 papers were found in the introductory
search: Cinahl (n = 238), Pub Med (n = 325), Web of Sci-
ence (n = 594). After checking for duplications, 908 pa-
pers remained. Screening the titles of the papers,
reading abstracts and then thoroughly reading the most
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relevant papers left us with seven journal articles to be
included in this review (Fig. 2).
Quality according to the Crowe critical appraisal tool
(CCAT)
To assess the quality of the papers that met the inclusion
criteria and thus were included in this review, we used the
Crowe Critical appraisal tool (CCAT). The tool consists of
a CCAT form and a CCAT user guide [43]. The CCAT
form consists of nine category items. The first eight cat-
egories are scored from 0 to 5. The 9th item states the total
sum score calculated from scores at categories 1 to 8.
Thus, sum scores may range from 0 to 40 points. By using
this tool, we had the opportunity to systematically assess
the quality of the included papers. The sum score of the
CCAT for each study is presented in Tables 1 and 2.
Fig. 1 Flow chart for search number one. This flow chart shows the inclusion process following the primary search
Fig. 2 Flow chart for search number two. This flow chart shows the inclusion process following search number two
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but not with the degree of HL
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Results
HL and generic QoL
The range of HL was presented differently in the in-
cluded studies. Five studies presented HL in groups from
mild to severe HL [44–48] and five presented the num-
ber of participants over different hearing range groups
[49–53]. Three studies gave no information on this [54–
56]. Still, it seems that in most of the included studies,
the lower limit of hearing loss was defined by a mean
hearing loss exceeding 25 dB HL in the better ear at the
octave frequencies from 0.5 to 4 kHz [57] (Table 1).
The included studies have used self-report question-
naires concerning QoL in adult persons with HL. The
number of participants varied from 30 to 2688 (Table 1).
Of the 13 studies included, 11 studies were cross-
sectional, one was longitudinal [44] and one was pro-
spective [45]. Seven studies used a generic QoL ques-
tionnaire [45, 46, 49–52, 54]. Two used a disease-
specific QoL questionnaire only [47, 48], while the
remaining four studies used a combination of generic
and disease-specific questionnaires (Table 1). Four stud-
ies used the SF-36 in order to measure generic QoL, of
which three employed the SF-36 alone [44, 49, 50]. One
study combined SF-36 and a disease-specific question-
naire, the Hearing Handicap Inventory for Elderly
(HHIE) [53].
In general, two of the included papers concluded that
HL is substantially associated with a reduced QoL [44,
54], whereas six claimed there is a weak correlation [47,
50–53, 56] and five no [45, 46, 48, 49, 55] significant
correlation between HL and generic QoL.
One study investigated both unilateral and bilateral
hearing loss (HL) [50], three studies reported bilateral
HL only [46, 49, 51] while the remaining nine studies
provided no information on this matter. In the study
that reported both unilateral and bilateral HL, persons
with unilateral HL did not report significantly lower gen-
eric QoL than persons without HL. In one study, worse
hearing at the high frequencies in male patients than in
female patients was reported [51]. Despite this, the
males had significantly better scores on generic QoL
compared to the females. Furthermore, non-verbal be-
havior that alleviates the consequences of HL on generic
QoL, such as pretending to hear, guessing what was said
and avoiding interactions, was reported less used by
men than by women [51].
In one study, the disease-specific questionnaire (HHIE)
and the SF-36 questionnaire were employed [49]. These
authors suggests that the SF-36 form lacks sensitivity
and specificity in assessing the impact of HL on QoL,
and suggests that untreated HL results in a significant
decline in QoL, as measured with the HHIE
questionnaire.
A study based on a relatively small population of 30
individuals, suggested that Individual Sound Amplifica-
tion Devices (ISADs) improved the overall QoL of the
individuals assessed [50]. At the same time, poor social
relationships and coping skills were risk factors for






































































EQ-5D EuroQol Group- 5 Dimensions
SF- 36 Medical Outcome Study (MOS) Short Form- 36 Health Survey Scale
15D 15 Dimension (a standardized self-administered measure of Health related Quality of Life)
LISZ Life Satisfaction Index, version Z
HMS Hearing Measurement Scale
PGWB Psychological General Well Being index
WHOQOL – bref Abbreviated version of the WHO QoL- 100 Quality of Life assessment
HHIE/HHIA Hearing Handicap Inventory for the Elderly/Adults
HHI-S HHIE - Screening version
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reduced QoL. The study suggested that HL is one of sev-
eral reasons why the elderly have depression, anxiety or
other noxious emotions.
The authors of a study that investigated the effect of
age at HL onset suggested that late onset HL seem to be
negatively correlated to QoL [24]. That is, people who
are born with HL or acquire HL in younger years seem
to adapt to their HL better, without the HL affecting
their QoL in adult life. This study also found that the
education level was lower in persons with HL, as only
14% of the participants had university-level education
[24].
One study found that there probably is an indirect
connection between HL and lower QoL. The authors ex-
plain this with a decline in general health that may occur
with increased age [50]. This is supported by a study
that included subjects with an average age of 71.7 years
that found that older people have more health problems
in general. Moreover, this study suggests that QoL has
many modulating factors, with HL being one of those
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factors [53]. Furthermore, this study suggests that it is
important to understand the synergetic effect of present
co-morbidities. This latter point is also addressed by a
study that suggests that a varying perception of HL may
be influenced by general life circumstances, and that one
should not ignore the synergetic effect of multiple co-
morbidities on the generic QoL scores [49].
HA use and generic QoL
Five studies measured QoL before the HA fitting, as well
as after three [46, 48, 53] or six [45, 56] months follow-
ing HA fitting. Four of these studies used generic ques-
tionnaires to measure QoL, while one used a disease-
specific questionnaire [48]. There seems to be evidence
that using HA alleviates HL and improves the quality of
social relationships. The study conducted by Stark and
Hickson [53] showed that the degree of HL, and extent
of HA use, seems to be important for improved hearing-
specific QoL. However, no significant improvement in
generic QoL was reported in this study. The two other
studies where QoL was measured after 3 months [46,
48], showed an improved QoL after using HA. In the
two studies where QoL was measured after 6 months,
one study reported that generic QoL measures yielded
equivocal results [56], perhaps due to the sensitivity of
the questionnaire being used. The other study [45] sug-
gests a marginal improvement in generic QoL in adults
with HL after using HA.
HL and distress, anxiety and/or depression
In the included studies, self-report questionnaires con-
cerning distress, anxiety or depression were collected
from participants who were adult persons over 18 years
with HL. The number of participants in the studies var-
ied from 90 to 18,318 (Table 2). The gender distribution
reported varied from 48 to 55% male participants [24,
58, 59]. One of the studies only had male participants
[60] (see Table 2). Three studies [59, 61, 62] used data
collected from large population surveys, in which data
on the correlation of HL and anxiety, depression and/or
distress were available. Two of the studies were based on
data collected from a national health register [24] or a
database [58]. The remaining two studies had data col-
lected from a prospective study [60] and a longitudinal
study [63]. The study conducted by Nachtegaal et al.
[61] presented results on both distress and depression,
whereas Gopinath et al. [62] presented results from dis-
tress. The rest of the included studies presented results
on anxiety and depression [24, 58–60, 63]. In these stud-
ies, associations between HL and distress, anxiety or de-
pression were only part of the results and conclusions
about factors negatively associated with HL.
Of the two included studies on distress, one study sug-
gested that hearing loss is associated with higher distress
and present depression. For every decibel increase in sig-
nal to noise ratio (SNR), the distress score increased by
2%, while the odds for developing moderate or severe
depression increased by 5% [61]. The other study sug-
gested that older HL adult patients are significantly
more likely to experience emotional distress [62].
In a study conducted by Hallberg et al. [51], the au-
thors suggest that the psychosocial consequences of the
HL cannot be predicted from audiometric data alone,
but must be seen in the context of coping strategies,
such as communication strategies. In one of these stud-
ies, two of the exclusion criteria were dementia and psy-
chiatric disease [49], while one study used limited
psychiatric disease as an exclusion criterion [46].
In general, there seems to be significantly higher levels
of both anxiety and depression in patients with severe or
profound HL compared to a reference population. This
seems to be the case even when taking into consider-
ation that some of the patients may have developed anx-
iety or depression prior to the onset of HL [24]. The
duration of HL seems to be positively correlated with
anxiety and depression levels, thereby suggesting that
the longer the amount of time with HL, the higher the
levels of anxiety and depression [60]. However, many of
the studies conclude that this conclusion is best
supported among females and younger individuals [58,
61].
In conclusion, there seems to be a strong association
between HL and depression [58, 59, 63], particularly in
women and those younger than 70 years [58, 61]. Anx-
iety [24, 60] and distress [61, 62] also seem more preva-
lent among patients with HL. Thus, there is highly likely
an association between distress and HL.
Discussion
The literature included in this review yield equivocal
findings regarding the association between generic QoL
and HL. Some authors argue that there are strong asso-
ciations [44, 54], while others find less strong [47, 50–
53, 56] or no relationships at all [45, 46, 48, 49, 55]. All
the included studies on associations between distress
and HL give firmly support to such a conclusion, in par-
ticular concerning depression among younger individ-
uals [58, 59, 61].
One of the two studies with the highest number of
subjects, supported an association between generic QoL
and HL and focused on older adults [44]. These subjects
showed more severe HL the older they were. The associ-
ation between increased age and severity of the HL in
this study makes it difficult to conclude whether the age
or the HL caused the change in generic QoL. Further-
more, when studying older adults by the use of self- re-
ported questionnaires like a QoL questionnaire, it is
important to ensure that the informants have the
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cognitive capacity needed to understand and complete
the questionnaire. We have found no report concerning
this matter in any of the published studies included in
this survey. This should be a matter of future improve-
ment of the investigational design.
Age is an example of a demographic variable that may
influence generic QoL [32]. Therefore, such variables
should be reported, and analyses carried out in order to
estimate the relative importance of these variables. Fur-
thermore, one should preferably adjust the QoL scores
by these variables as additional analyses. This has to
some extent been reported within the included papers,
but no exhaustive study on this matter has been pre-
sented. Most of the included studies, however, do not
lend any substantial support to the claim that demo-
graphic variables are of high importance concerning
generic QoL and HL.
HL may be unilateral or bilateral. Standard procedure
would be to report hearing levels from the least affected
ear [64]. Nevertheless, to differentiate between the two
conditions should be of importance and this was done in
one investigation [50]. It should be of interest to study
subjects with unilateral HL more extensively in order to
acquire knowledge of any impaired QoL in this group.
Many of the studies yielding the highest CCAT-scores
employed SF-36 as QoL measure, which only to some
extent represents a generic HRQoL instrument. The SF-
36 does not cover the full range of QoL. General symp-
toms are not covered [49]. More specifically health re-
lated QoL generic questionnaires could additionally be
utilized in order to study whether HL affects a broader
array of symptoms in persons with HL [44, 49, 53].
The associations between HL and distress, anxiety and
depression are better documented than the general rela-
tionship between QoL and HL. Many factors may ex-
plain this relationship. HL may be the causative factor
secondary to the social isolation caused by HL. Further-
more present comorbidity may explain both. This needs
to be studied further. Distressed persons are expected to
have lowered generic QoL [40]. Therefore, solely based
on this association, generic QoL is suggested to be low-
ered among HL patients.
Regarding justifying HL treatment, improvements in
both generic and disease-specific QoLs are important
outcome measures, both clinically and for researchers
[20]. To what extent individuals with untreated HL have
lower generic QoL [49] is therefore interesting to study.
A low generic QoL baseline subsequently improved after
treatment constitutes an excellent HA treatment argu-
ment. A low baseline QoL among HL patients would
also lend support to offering a larger range of treatments
to this group beyond fitting a hearing aid [65]. The stud-
ies where generic QoL were measured following HA fit-
ting after 3 months [46, 48, 53] or 6 months [45, 56]
show equivocal findings. Some of these studies suggest
increased generic QoL caused by the use of a HA, while
other studies explain HA use as one of several possible
factors that leads to better generic QoL. In conclusion,
future generic QoL studies should be encouraged since a
firm conclusion about HL and generic QoL has not yet
been reached.
Despite the fact that HL may cause poorer generic
QoL, and that using a HA may improve generic QoL,
some studies suggest that many who are fitted with
HAs, used their HA only to a limited degree [66]. This
may be caused by the patients not receiving sufficient
help and follow-up to master the HA [67]. Other studies
on treatment show that HAs are an important contribu-
tor to increased QoL in HL patients [65]. Some studies
suggest that using HAs over time seems to reverse the
adverse effects of HL on QoL [62]. The process of HA
fitting may also carry a placebo- effect. If so, this could
also indicate that, as previously suggested [33, 68–70]
concerning other diseases, generic QoL to a large extent
mainly originates from the personality and thus stays
more or less stable, regardless of the severity of HL.
We suggest a need for including both PROMs and
physical measures in all hearing assessments [50]. Many
modern HAs have the capability to log the actual use of
the HAs in addition to the patient’s self-reported use. By
collecting both physical and QoL data repeatedly, more
robust data would be available to evaluate the strength
of the relationship between the actual use of HAs and
eventual improvements in QoL. By including control
groups within research, one could in addition obtain
more conclusive answers as to whether an improved
QoL following HA fitting may be considered a Haw-
thorne effect [71], i.e. if the QoL improvement during
HA fitting is due to the attention in this period.
For researchers, it also seems reasonable to measure
additional potentially explaining variables, at several
time points, when trying to determine what affects the
QoL in persons with HL. Such screening would provide
the opportunity to unravel why and to what extent pa-
tients with HL has lowered QoL, or even psychiatric dis-
ease. This could provide important clues on how to
better help these patients. Systematic studies of HL
treatment, with this perspective included, could likely
provide evidence on how to better the health care ser-
vices for patients with HL.
Data were collected using a literature review design
with the aim to identify relevant literature published
from the timespan 2000–2016 concerning patients with
HL and the evaluation of their generic QoL. When using
a limited time span there will always be a risk of missing
important publications. This represents a possible weak-
ness in our study that could have been overcome by ex-
tending the timespan to include previous years.
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Furthermore, we did not systematically search the refer-
ence list of the included papers for additional papers.
This may have provided additional relevant papers and
this represents a weakness in our design. Also, differ-
ences in sample sizes, age of subjects, hearing loss con-
figurations and methodological presentations between
studies complicated the comparison of results between
studies.
Conclusions
The main aim of this study was to review studies about
the relationship between HL and QoL. Results of our re-
view show that the majority of such studies suggest that
HL reduces QoL. Those studies that also measured QoL
after fitting of HAs suggest that HA fitting to some de-
gree improves generic QoL at follow-up within the first
year. A supporting aim was to review studies on the re-
lationship between HL and distress, anxiety and mood.
Results of our review show that HL is a risk factor for
distress. We suggest that systematic studies of HL treat-
ment, with a QoL perspective included, could provide
evidence on how to better the health care services for
patients with HL. As a consequence of our findings we
suggest a need for including both PROMs and physical
measures in persons with hearing loss, both at baseline
and as outcome measures. Further research is needed to
explore the relationship between HL and generic QoL,
as well as the importance of various influencing variables
on this relationship.
Additional file
Additional file 1: PRISMA 2009 Checklist. (DOC 62 kb)
Abbreviations
HA: Hearing aids; HL: Hearing loss; ISAD: Individual sound amplification




This research received no specific grant from any funding agency in the
public, commercial or not-for-profit sector.
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated
or analysed during the current study.
Authors’ contributions
ØN performed the literature search and read all abstracts. ØN and PH read
relevant papers to identify those that met the inclusion criteria. ØN wrote
the initial results section. ØN and PH wrote an initial manuscript based on
these results. JB, FV, AKA and HJA contributed substantially to the revision of
all parts of the initial manuscript. All authors read and approved the final
manuscript.
Ethics approval and consent to participate
Not applicable due to study design and article type.
Consent for publication
Not applicable due to study design and article type.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Otolaryngology/Head and Neck Surgery, Haukeland
University Hospital, Bergen, Norway. 2Department of Clinical Medicine,
Faculty of Medicine and Dentistry, University of Bergen, Bergen, Norway.
3Faculty of Health and Social Sciences, Bergen University College, Bergen,
Norway. 4Department of Clinical Science, Section of Logopedics, Phoniatrics
and Audiology, Lund University, Lund, Sweden. 5Department of Health
Science, Faculty of Health Sciences, University of Stavanger, Stavanger,
Norway.
Received: 21 March 2017 Accepted: 2 January 2018
References
1. Olusanya BO, Neumann KJ, Saunders JE. The global burden of disabling
hearing impairment: a call to action. Bull World Health Organ. 2014;92(5):
367–73.
2. Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC,
Charlson FJ, Chen AZ. Global, regional, and national incidence, prevalence,
and years lived with disability for 310 diseases and injuries, 1990-2015: a
systematic analysis for the global burden of disease study 2015. Lancet.
2016;388(10053):1545.
3. Pacala JT, Yueh B. Hearing deficits in the older patient:“I didn't notice
anything”. JAMA. 2012;307(11):1185–94.
4. Gates GA, Mills JH. Presbycusis. Lancet. 2005;366(9491):1111–20.
5. Lin FR, Thorpe R, Gordon-Salant S, Ferrucci L. Hearing loss prevalence and
risk factors among older adults in the United States. J Gerontol A Biol Sci
Med Sci. 2011;66(5):582–90.
6. Vila PM, Thomas T, Liu C, Poe D, Shin JJ. The burden and epidemiology of
eustachian tube dysfunction in adults. Otolaryngol Head Neck Surg. 2017;
156(2):278–84.
7. Masterson EA, Deddens JA, Themann CL, Bertke S, Calvert GM. Trends in
worker hearing loss by industry sector, 1981–2010. Am J Ind Med. 2015;
58(4):392–401.
8. Naz S, Imtiaz A, Mujtaba G, Maqsood A, Bashir R, Bukhari I, Khan MR,
Ramzan M, Fatima A, Rehman AU. Genetic causes of moderate to severe
hearing loss point to modifiers. Clin Genet. 2017;91(4):589–98.
9. Shargorodsky J, Curhan SG, Curhan GC, Eavey R. Change in prevalence of
hearing loss in US adolescents. JAMA. 2010;304(7):772–8.
10. Sprinzl G, Riechelmann H. Current trends in treating hearing loss in elderly
people: a review of the technology and treatment options–a mini-review.
Gerontology. 2010;56(3):351–8.
11. Laplante-Lévesque A, Hickson L, Worrall L. Rehabilitation of older adults
with hearing impairment: a critical review. J Aging Health. 2010;22(2):
143–53.
12. Wehrlen L, Krumlauf M, Ness E, Maloof D, Bevans M. Systematic collection of
patient reported outcome research data: a checklist for clinical research
professionals. Contemp Clin Trials. 2016;48:21–9.
13. Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM.
Evidence-based guidelines for determination of sample size and
interpretation of the European Organisation for the Research and
Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin
Oncol. 2010;29(1):89–96.
14. Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz
C, Revicki DA, Moinpour CM, McLeod LD. ISOQOL recommends minimum
standards for patient-reported outcome measures used in patient-centered
outcomes and comparative effectiveness research. Qual Life Res. 2013;22(8):
1889–905.
15. Terwee C, Prinsen C, Garotti MR, Suman A, De Vet H, Mokkink L. The quality
of systematic reviews of health-related outcome measurement instruments.
Qual Life Res. 2016;25(4):767–79.
Nordvik et al. BMC Ear, Nose and Throat Disorders  (2018) 18:1 Page 11 of 13
16. Fayers PM, Machin D. Quality of life: the assessment, analysis and
interpretation of patient-reported outcomes. John Wiley & Sons, Wiley
Online Library; 2013.
17. Fayed N, De Camargo OK, Kerr E, Rosenbaum P, Dubey A, Bostan C,
Faulhaber M, Raina P, Cieza A. Generic patient-reported outcomes in child
health research: a review of conceptual content using World Health
Organization definitions. Dev Med Child Neurol. 2012;54(12):1085–95.
18. Cieza A, Oberhauser C, Bickenbach J, Chatterji S, Stucki G. Towards a
minimal generic set of domains of functioning and health. BMC Public
Health. 2014;14(1):218.
19. Heggdal L. Clinical application and psychometric properties of a Norwegian
questionnaire for the self-assessment of communication in quiet and
adverse conditions using two revised APHAB subscales. J Am Acad Audiol.
2018;29(1):25–34.
20. Ciorba A, Bianchini C, Pelucchi S, Pastore A. The impact of hearing loss on
the quality of life of elderly adults. Clin Interv Aging. 2012;7:159.
21. Sirgy MJ, Michalos AC, Ferriss AL, Easterlin RA, Patrick D, Pavot W. The
qualityity-of-life (QOL) research movement: past, present, and future. Soc
Indic Res. 2006;76(3):343–466.
22. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey
(SF-36): I. Conceptual framework and item selection. Med Care. 1992;
30(6):473–83.
23. Ware JE Jr. SF-36 health survey update. Spine. 2000;25(24):3130–9.
24. Carlsson P-I, Hjaldahl J, Magnuson A, Ternevall E, Edén M, Skagerstrand Å,
Jönsson R. Severe to profound hearing impairment: quality of life, psychosocial
consequences and audiological rehabilitation. Disabil Rehabil. 2015;37(20):
1849–56.
25. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic
quality-of-life instruments. PharmacoEconomics. 2000;17(1):13–35.
26. Németh G. Health related quality of life outcome instruments. Eur Spine J.
2006;15(1):S44–51.
27. Fayers P, Bottomley A, Group EQoL. Quality of life research within the
EORTC—the EORTC QLQ-C30. Eur J Cancer. 2002;38:125–33.
28. Ludwig K, Schulenburg J-MG, Greiner W. Valuation of the EQ-5D-5L with
composite time trade-off for the German population–an exploratory study.
Health Qual Life Outcomes. 2017;15(1):39.
29. Larsen FB, Pedersen MH, Friis K, Glümer C, Lasgaard M. A latent class analysis of
multimorbidity and the relationship to socio-demographic factors and health-
related quality of life. A national population-based study of 162,283 Danish
adults. PLoS One. 2017;12(1):e0169426.
30. Monzani D, Galeazzi G, Genovese E, Marrara A, Martini A. Psychological profile
and social behaviour of working adults with mild or moderate hearing loss. Acta
Otorhinolaryngol Ital. 2008;28(2):61.
31. Wahl H-W, Heyl V, Schilling O. Robustness of personality and affect relations
under chronic conditions: the case of age-related vision and hearing
impairment. J Gerontol B Psychol Sci Soc Sci. 2012;67(6):687–96.
32. Montejo P, Montenegro M, Fernández MA, Maestú F. Memory complaints in the
elderly: quality of life and daily living activities. A population based study. Arch
Gerontol Geriatr. 2012;54(2):298–304.
33. Dunne S, Mooney O, Coffey L, Sharp L, Desmond D, Timon C, O'Sullivan E,
Gallagher P. Psychological variables associated with quality of life following
primary treatment for head and neck cancer: a systematic review of the
literature from 2004 to 2015. Psycho-Oncology. 2017;26(2):149–60.
34. Aarstad AK, Beisland E, Osthus AA, Aarstad HJ. Distress, quality of life, neuroticism
and psychological coping are related in head and neck cancer patients during
follow-up. Acta Oncol. 2011;50(3):390–8.
35. Beisland E: Health-related quality of life, distress and psychosocial factors in
head and neck and renal cancer patients. Quality of life in HNSCC and RCC
patients. 2015.
36. World Health Organization. ICD-10 Version: 2016. http://apps.who.int/
classifications/icd10/browse/2016/en. Accessed 16 Dec 2016.
37. Association AP. Diagnostic and statistical manual of mental disorders. (DSM-
5). Washington, DC: American Psychiatric Association; 2013.
38. Ridner SH. Psychological distress: concept analysis. J Adv Nurs. 2004;45(5):
536–45.
39. Keyes KM, Nicholson R, Kinley J, Raposo S, Stein MB, Goldner EM, Sareen J. Age,
period, and cohort effects in psychological distress in the United States and
Canada. Am J Epidemiol. 2014;179(10):1216–27.
40. Faller H, Schuler M, Richard M, Heckl U, Weis J, Küffner R. Effects of psycho-
oncologic interventions on emotional distress and quality of life in adult patients
with cancer: systematic review and meta-analysis. J Clin Oncol. 2013;31(6):782–93.
41. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP,
Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement
for reporting systematic reviews and meta-analyses of studies that
evaluate health care interventions: explanation and elaboration. PLoS
Med. 2009;6(7):e1000100.
42. Cronin P, Ryan F, Coughlan M. Undertaking a literature review: a step-by-
step approach. Br J Nurs. 2008;17(1):38–43.
43. Crowe M. Crowe critical appraisal tool (CCAT) user guide. Scotland: Conchra
House; 2013.
44. Dalton DS, Cruickshanks KJ, Klein BE, Klein R, Wiley TL, Nondahl DM. The
impact of hearing loss on quality of life in older adults. The Gerontologist.
2003;43(5):661–8.
45. Niemensivu R, Manchaiah V, Roine RP, Kentala E, Sintonen H. Health-related
quality of life in adults with hearing impairment before and after hearing-
aid rehabilitation in Finland. Int J Audiol. 2015;54(12):967–75.
46. Mondelli MFCG, de Souza PJS. Quality of life in elderly adults before and
after hearing aid fitting. Braz J Otorhinolaryngol. 2012;78(3):49–56.
47. Espmark A-KK, Rosenhall U, Erlandsson S, Steen B. The two faces of
presbyacusis: hearing impairment and psychosocial consequences: Los dos
rostros de la presbiacusia: Impedimento auditivo y consecuencias
psicosociales. Int J Audiol. 2002;41(2):125–35.
48. Lotfi Y, Mehrkian S, Moossavi A, Faghih-Zadeh S. Quality of life
improvement in hearing-impaired elderly people after wearing a hearing
aid. Arch Iran Med. 2009;12(4):365–70.
49. Chew H, Yeak S. Quality of life in patients with untreated age-related
hearing loss. J Laryngol Otol. 2010;124(8):835–41.
50. Chia E-M, Wang JJ, Rochtchina E, Cumming RR, Newall P, Mitchell P.
Hearing impairment and health-related quality of life: the Blue Mountains
hearing study. Ear Hear. 2007;28(2):187–95.
51. Hallberg LR-M, Hallberg U, Kramer SE. Self-reported hearing difficulties,
communication strategies and psychological general well-being (quality of
life) in patients with acquired hearing impairment. Disabil Rehabil. 2008;
30(3):203–12.
52. Helvik A-S, Jacobsen G, Hallberg LR. Psychological well-being of adults with
acquired hearing impairment. Disabil Rehabil. 2006;28(9):535–45.
53. Stark P, Hickson L. Outcomes of hearing aid fitting for older people
with hearing impairment and their significant others. Int J Audiol.
2004;43(7):390–8.
54. Miyakita T, Ueda A, Zusho H, Kudoh Y. Self-evaluation scores of hearing
difficulties and quality of life components among retired workers with
noise-related hearing loss. J Sound Vib. 2002;250(1):119–28.
55. Meyer JM, Kashubeck-West S. Well-being of individuals with late-deafness.
Rehabil Psychol. 2013;58(2):124.
56. Vuorialho A, Karinen P, Sorri M. Effect of hearing aids on hearing disability
and quality of life in the elderly: Efecto de los auxiliares auditivos (AA) en la
discapacidad auditiva y la calidad de vida de los ancianos. Int J Audiol.
2006;45(7):400–5.
57. Agrawal Y, Platz EA, Niparko JK. Prevalence of hearing loss and differences
by demographic characteristics among US adults: data from the National
Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med. 2008;
168(14):1522–30.
58. Tseng C-C, Hu L-Y, Liu M-E, Yang AC, Shen C-C, Tsai S-J. Risk of depressive
disorders following sudden sensorineural hearing loss: a nationwide
population-based retrospective cohort study. J Affect Disord. 2016;197:94–9.
59. Li C-M, Zhang X, Hoffman HJ, Cotch MF, Themann CL, Wilson MR. Hearing
impairment associated with depression in US adults, National Health and
nutrition examination survey 2005-2010. JAMA Otolaryngol Head Neck Surg.
2014;140(4):293–302.
60. Cetin B, Uguz F, Erdem M, Yildirim A. Relationship between quality of life,
anxiety and depression in unilateral hearing loss. J Int Adv Otol. 2010;6(2):252-7.
61. Nachtegaal J, Smit JH, Smits C, Bezemer PD, Van Beek JH, Festen JM,
Kramer SE. The association between hearing status and psychosocial
health before the age of 70 years: results from an internet-based
national survey on hearing. Ear Hear. 2009;30(3):302–12.
62. Gopinath B, Schneider J, Hickson L, McMahon CM, Burlutsky G, Leeder
SR, Mitchell P. Hearing handicap, rather than measured hearing
impairment, predicts poorer quality of life over 10 years in older adults.
Maturitas. 2012;72(2):146–51.
63. Kramer SE, Kapteyn TS, Kuik DJ, Deeg DJ. The association of hearing
impairment and chronic diseases with psychosocial health status in older
age. J Aging Health. 2002;14(1):122–37.
Nordvik et al. BMC Ear, Nose and Throat Disorders  (2018) 18:1 Page 12 of 13
64. Gurgel RK, Jackler RK, Dobie RA, Popelka GR. A new standardized format for
reporting hearing outcome in clinical trials. Otolaryngol Head Neck Surg.
2012;147(5):803–7.
65. Chisolm TH, Johnson CE, Danhauer JL, Portz LJ, Abrams HB, Lesner S,
McCarthy PA, Newman CW. A systematic review of health-related quality of
life and hearing aids: final report of the American Academy of Audiology
task force on the health-related quality of life benefits of amplification in
adults. J Am Acad Audiol. 2007;18(2):151–83.
66. McCormack A, Fortnum H. Why do people fitted with hearing aids not wear
them? Int J Audiol. 2013;52(5):360–8.
67. Lupsakko TA, Kautiainen HJ, Sulkava R. The non-use of hearing aids in
people aged 75 years and over in the city of Kuopio in Finland. Eur Arch
Otorhinolaryngol Head Neck. 2005;262(3):165–9.
68. Aarstad AK, Aarstad HJ, Olofsson J. Personality and choice of coping predict
quality of life in head and neck cancer patients during follow-up. Acta
Oncol. 2008;47(5):879–90.
69. Aarstad H, Aarstad A, Birkhaug E, Bru E, Olofsson J. The personality and
quality of life in HNSCC patients following treatment. Eur J Cancer. 2003;
39(13):1852–60.
70. Beisland E, Aarstad AKH, Osthus AA, Aarstad HJ. Stability of distress and
health-related quality of life as well as relation to neuroticism, coping and
TNM stage in head and neck cancer patients during follow-up. Acta
Otolaryngol. 2013;133(2):209–17.
71. Wickström G, Bendix T. The “Hawthorne effect”—what did the original
Hawthorne studies actually show? Scand J Work Environ Health. 2000;26(4):
363–7.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Nordvik et al. BMC Ear, Nose and Throat Disorders  (2018) 18:1 Page 13 of 13
